Home
Patients
Professionals
Trials
News
About
Neurology Image Library
Search
The Internet Stroke Center
Trials Registry
Clinical Trials
Interventions
Conditions
Sponsors
Join
Sign In
Interventions
Search for an intervention by name or type, and view related trials.
Simvastatin - Drug
Related Trials
Title
Acronym
Phase
Status
MRC / BHF Heart Protection Study
HPS
N/A
Fast Assessment of Stroke and Transient ischemic attack to prevent Early Recurrence - Pilot Study
FASTER
N/A
Markers of Inflammation after Simvastatin in Ischemic Cortical Stroke
MISTICS
N/A
Simvastatin After Aneurysmal Subarachnoid Hemorrhage
N/A
A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm
1/2
Effect Of Simvastatin On Endothelial Dysfunction, Fibrinolysis, Coagulation And Inflammation After Aneurysmal Subarachnoid Hemorrhage
SIMSAB
N/A
Simvastatin For Intracerebral Hemorrhage Study
2
Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
N/A
Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)
1/2
Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial
STASH
3
IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (Study P04103AM3)
3
Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)
MCAT
2
The Indian POLYCAP Study (TIPS)
N/A
Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578AM3)(COMPLETED)
ENHANCE
3
Stroke Treatment with Acute Reperfusion and Simvastatin
STARS07
N/A
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China
SMART
N/A
Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)
2/3
Stroke Treatment With Acute Reperfusion and Simvastatin
4
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
4
Niacin Plus Statin to Prevent Vascular Events
3
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
HPS2-THRIVE
3